VoicePort Launches PharmaPhonetics™ Patient Adherence at Leading Patient Compliance and Pharmaceutical Event
VoicePort sponsors CBI’s 7th Annual Forum on Patient Compliance, Adherence and Persistency in Philadelphia, PA, April 24-25.
Rochester, NY (PRWEB) April 24, 2008 -- Patient compliance in the healthcare and pharmaceutical industries takes center stage when VoicePort launches its PharmaPhonetics™ Patient Adherence at CBI’s 7th Annual Forum on Patient Compliance, Adherence and Persistency today at the Doubletree hotel in Philadelphia, PA. Lack of patient medication compliance is a widely recognized issue, costing patients and pharmaceutical companies billions each year.
VoicePort’s PharmaPhonetics™ Patient Adherence delivers a cost-effective, personalized interactive experience that lets pharmaceutical clients speak to their entire audience one at a time. Using proprietary, patent-pending automated speech recognition technology, PharmaPhonetics enables personalized permission-based phone calls and text messaging/SMS that dynamically respond to individual patient needs. For a fraction of the cost of traditional programs, the program can help pharmaceutical manufacturers improve patient compliance and build brand loyalty, and increase reach and frequency by offering an alternative ubiquitous intervention vehicle to reach more patients.
Greg Kochuk, Vice President of Sales, said: “We’re excited to bring our product to market at the leading patient compliance event. This year’s forum theme is about improving product usage through integrated patient-centered initiatives, and that is exactly what the PharmaPhonetics Patient Adherence solution is all about.” He continued, “Our turn key programs can integrate with existing programs or be part of new multi-disciplinary initiatives, and our personalized, interactive approach creates a natural and comfortable experience that is very patient-centric.”
About VoicePort
Founded in 2002, we’ve deployed applications at more than 130 customer sites in North America. Nuance and Genesys, our partners, are the top technology speech providers. To find out more about our products and services, please visit: www.voiceport.net.
VoicePort helps clients control costs and efficiently communicate with customers and patients by using advanced speech recognition self-service technology to automate interactions. VoicePort develops configurable solutions for niche markets such as the media and pharmaceutical verticals. PharmaPhonetics™ is a suite of tailored turn key scaleable programs and applications that include PharmaPhonetics Patient Adherence, a patient medication compliance solution, and PharmaPhonetics Speech Enabled Market Research (SEMR), which enables pharmaceutical manufacturers to gain deep insights from hundreds of physicians.
Press Contact:
Elisha Kasinskas
Sr. Marketing Manager
585-248-9289 x1124
###
|
